ArticleMolecular oncology2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer.
Nicolas Gordon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it